Back to search
FDAFDA · Food and drugs·Recall number D-0675-2025

Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American Health Packaging, Columbus, OH 43217. Carton NDC 60687-594-21; (Individual Dose NDC: 60687-594-11)

Published October 8, 2025 · Recall initiated: September 15, 2025

Summary

FDA records drug Class II recall D-0675-2025, published October 8, 2025 and initiated September 15, 2025. Recalling firm: Amerisource Health Services LLC; Status: Ongoing; Reported quantity: 360 cartons; Lot: Lot #: 1024078, Exp. Date 08/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications.

What to do

Voluntary: Firm initiated · Letter

Get an email if CARBAMAZEPINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CARBAMAZEPINE
Manufacturer
Amerisource Health Services LLC
Distributor
Nationwide in the USA.
Lot
Lot #: 1024078, Exp. Date 08/31/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Carbamazepine Extended-Release Tablets, USP 400 mg, 30 Tablets per carton (3x10 unit dose cards), Rx Only, American Health Packaging, Columbus, OH 43217. Carton NDC 60687-594-21; (Individual Dose NDC: 60687-594-11) recalled?

Yes. FDA published recall D-0675-2025 on October 8, 2025. Reported hazard: Failed Dissolution Specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CARBAMAZEPINE.